Assessment of IAP (inhibitor of apoptosis) proteins as predictors of response to chemotherapy in advanced non-small-cell lung cancer patients

Annals of Oncology

Volumn 12, Issue 6, 2001, Pages 799-805

  Ferreira, C G ^a   Van Der Valk, P ^a   Span, S W ^a   Jonker, J M ^a   Postmus, P E ^a   Kruyt, F A E ^a   Giaccone, G ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Apoptosis; Caspases; Chemotherapy; IAPs; Lung carcinoma; Response

Indexed keywords

ANTINEOPLASTIC AGENT; INHIBITOR OF APOPTOSIS PROTEIN;

ADULT; ADVANCED CANCER; AGE; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CELL NUCLEUS; CELLULAR DISTRIBUTION; CHEMOSENSITIVITY; CONTROLLED STUDY; CYTOPLASM; DRUG RESPONSE; FEMALE; GENDER; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR CELL; TUMOR DIFFERENTIATION; TUMOR VOLUME;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBITOR OF APOPTOSIS PROTEINS; INSECT PROTEINS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROTEINS; STATISTICS; SURVIVAL ANALYSIS; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 0034954219     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011167113067     Document Type: Article

References (46)

1. An update on North American randomized studies in non-small cell lung cancer
2. Immunohistochemical detection of DNA topoisomerase II alpha, P-glycoprotein and multidrug resistance protein (MRP) in small-cell and non-small-cell lung cancer
3. Parallel assessment of glutathione-based detoxifying enzymes, O6-alkylguanine-DNA alkyltransferase and P-glycoprotein as indicators of drug resistance in tumor and normal lung of patients with lung cancer
4. Expression of the multidrug resistance-associated protein (MRP) gene in non-small-cell lung cancer
5. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
6. Apoptosis in cancer therapy: Crossing the threshold
7. Apoptosis and the immune system
8. Human ICE/CED-3 protease nomenclature
9. Caspase activation involves the formation of the aposome, a large (approximately 700 kDa) caspase-activating complex
10. Caspases: The executioners of apoptosis
11. Proteases to die for
12. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis
13. Chemotherapy triggers apoptosis in a caspase-8-dependent and mitochondria-controlled manner in the non-small-cell lung cancer cell line NCI-H460
14. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
15. An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9
16. Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization
17. Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors
18. The inhibitors of apoptosis (IAPs) and their emerging role in cancer
19. IAP family proteins - Suppressors of apoptosis
20. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy
21. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
22. X-linked IAP is a direct inhibitor of cell-death proteases
23. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases
24. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases
25. Revisions in the international system for staging lung cancer
26. Dangers of using 'optimal' cutpoints in the evaluation of prognostic factors
27. Reporting results of cancer treatment
28. A new internal-ribosome-entry-site motif potentiates XIAP-mediated cytoprotection
29. Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias
30. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer
31. Expression of a novel anti-apoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas
32. Assessment of XIAP (X-linked inhibitor of apoptosis) as a novel prognostic marker in radically resected non-small-cell lung cancer (NSCLC) patients
33. Dysregulation of apoptosis in cancer
34. Prognostic significance of survivin expression in diffuse large B-cell lymphomas
35. Expression and prognostic significance of survivin in de novo acute myeloid leukaemia
36. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition
37. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins
38. Expression and Genetic Analysis of XIAP-Associated Factor 1 (XAF1) in Cancer Cell Lines
39. Livin, a novel inhibitor-of-apoptosis (IAP) family member
40. Activation of NF-kappa B by XIAP, the X chromosome-linked inhibitor of apoptosis, in endothelial cells involves TAK1
41. Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells
42. Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells
43. A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers
44. Apoptosis and chemoresistance in human ovarian cancer: Is Xiap a determinant?
45. Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting
46. A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy